3 ms·

Panel advising US FDA rejects MDMA for post-traumatic stress disorder

• JumpCrisscross 2y ago
  "Following a nine-hour evidence session, the FDA advisory committee, composed of mental health and medical experts, voted by a margin of 9 to 2 that the available data did not prove that the drug was an effective treatment of PTSD in combination with therapy. In a second vote, the panel also concluded the benefits of the treatment did not outweigh the risks, with the vote carried by 10 to 1."
• gnabgib 2y ago
  Discussions faces doubt [0](26 points, 2 days ago, 18 comments) rejected [1][2] (3 hour ago) [0]: https://news.ycombinator.com/item?id=40558487 https://news.ycombinator.com/item?id=40558487 [1]: https://news.ycombinator.com/item?id=40580334 https://news.ycombinator.com/item?id=40580334 [2]: https://news.ycombinator.com/item?id=40580525 https://news.ycombinator.com/item?id=40580525
• yawpitch 2y ago
  Alternative headline: Panel advising US FDA decides PTSD sufferers should enter illegal narcotics market.
• abusevictim 2y ago
  [dead]